Advertisement GYROS - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

GYROS

Logo
LATEST PRESS RELEASES
January 30, 2013

Gyros Expands Asian Distribution to Singapore

Gyros AB, a leader in utilization of microfluidic technologies to miniaturize and automate immunoassays, announced today that Bio Laboratories Pte...
pharmacuetical business review
January 30, 2013

Gyros AB Appoints Dr. Claus Braestrup to the Board of Directors

Gyros AB, a leader in utilization of microfluidic technologies to miniaturize and automate immunoassays, announced Dr. Claus Braestrup has joined...
pharmacuetical business review


LATEST VIDEOS

GYROS

Gyros AB is the world leader in utilization of microfluidic technologies to miniaturize and automate immunoassays. The Gyroslab â„¢xP immunoassay platform increases productivity and efficiency during development of biotherapeutics and vaccines, saving time and labor. Major biopharmaceutical companies and their service providers utilize the Gyros platform to boost time-critical workflows and meet increasing regulatory demands.

Easy assay transfer between sites and from development to regulated environments

Spanning the entire spectrum of immunoassays, the platform cuts the time to result significantly. Faster development times, and unattended running of assays at nano-liter scale, save labor and sample. The ease of assay transfer between sites and from development to regulated environments is unsurpassed in the industry. The company is based in Uppsala, Sweden and has regional sales and support offices in the USA and Europe, and a growing network of distributors.

Revolutionary immunoassays

Gyrolabâ„¢ xP workstation miniaturizes, integrates and automates analysis of large numbers of samples in parallel – minimizing user error, massively increasing productivity, cutting time to validated assay and final result, and freeing up analysts’ time. Same-day results support rapid and effective decision making. Each step in the assay workflow is controlled by software and results are evaluated by Gyrolabâ„¢ software, or exported to a LIMS.

Gyros’ technology is being applied in a range of applications for the development of biotherapeutics:

  • Biomarker monitoring
  • Pharmacokinetics (PK)
  • Pharmacodynamics (PD)
  • Immunogenicity (ADA)
  • Product quantification (lgG titer)
  • Impurity testing (HCP, protein A)

For more information click here

Contact

Gyros AB
Uppsala Science Park
SE-751 83 Uppsala, Sweden
Visiting address:
Dag Hammarskjölds väg 54B
Telephone: +4618 56 63 00
Fax: +46 (0)18 56 63 50
Email: information@gyros.com

Gyrolab ADA CD

Miniaturization makes detecting anti-drug antibodies simple even in the presence of a high drug concentration. Gyrolab ADA CD enables you to efficiently and automatically pretreat your samples and run drug-tolerant ADA analysis, generating results in less than an hour.

Integrates sample pretreatment. Uniformly.The individual microstructures integrate acid dissociation to minimize variation between samples. Dedicated Gyrolab ADA Software supports assay development and validation for cut point determination, screening and confirmatory analysis.

Gyrolab Bioaffy CDs

Using our range of Gyrolab Bioaffyâ„¢ CD's, you can easily develop robust nanoliter-scale immunoassays with a broad dynamic range. The CD's minimize reagent and sample consumption and deliver results in less than 1 hour.

Dynamic range extended. Reliably.The CD's offer full flexibility in assay design to quantify any protein, providing you have a suitable binding pair (biotinylated capture and Alexa Fluorâ„¢ detection reagents).You can select the appropriate CD for a specific immunoassay based on the required dynamic range, the analyte concentration, the quality of reagents, and the assay format.…

Gyrolab software modules

From sample, to assay, to report. With ease.Gyrolab software helps you speed up assay development, run the entire system simply and intuitively, and analyze the data with ease. The software modules for Gyrolab workstation are 21 CFR Part 11 compliant, so you can use them from research through to regulated GxP environments, and you can…

Gyrolab xP workstation

Gyrolabâ„¢ xP workstation automates finely controlled immunoassays in identical microfluidic channels. The CD is spun at precise speed and time to ensure optimal reactions. Samples are processed simultaneously in parallel, resulting in uniform conditions for all assays.

Nano-liter scale immunoassays. With precision.The system transfers samples and reagents from microplates to each microstructure within a Gyrolab CD. Up to five CD's can be processed in one run. Results are obtained in less than an hour, ready for automated evaluation by Gyrolab Evaluator software or export to a LIMS. All software products are 21…

Rexxip buffers

Rexxipâ„¢ buffers help you to save time in assay development and get the best performance from your immunoassay. The buffers preserve the integrity of the sample while it flows through the CD, enhance binding between analyte and reagent, and minimize non-specific binding in the capture column.

Reaction conditions. Under control.Rexxip buffers cover a wide range of antibodies and other analytes. Select the Rexxip buffer most suitable for your application using the table below.A, Animal samples; H, Human samples. Rexxip-max buffers are designed for sample dilutions 1:1. Regular Rexxip buffers should be used for sample dilutions > 1:1.
Quick Contact GYROS
Quick Contact GYROS
Quick Contact GYROS


Quick Contact GYROS
Quick Contact GYROS
Quick Contact GYROS


Contact GYROS

Optional Data

Almost there, complete this form and hit the submit button to complete your registration.

Confirmation

Finally, complete a quick security check and confirm terms and conditions:

Quick Contact GYROS